BartLClarkeMD
Endocrinology • Rochester, MNDiabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine, Parathyroid
Professor of Medicine
Dr. Clarke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1992- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1986 - 1989
David Geffen School of Medicine at UCLAClass of 1986
Certifications & Licensure
MN State Medical License 1987 - 2025
IA State Medical License 1998 - 2006
IL State Medical License 1994 - 1999- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 1996
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- A Registry for Participants With Chronic Hypoparathyroidism Start of enrollment: 2013 Jul 30
- A Clinical Study Investigating the Safety, Tolerability, PK and PD of PCO371 in Patients With Hypoparathyroidism Start of enrollment: 2020 Jul 23
Publications & Presentations
PubMed
- 119 citationsEvaluation and Management of Primary Hyperparathyroidism: Summary Statement and Guidelines from the Fifth International Workshop.John P Bilezikian, Aliya A Khan, Shonni J Silverberg, Ghada El-Hajj Fuleihan, Claudio Marcocci
Journal of Bone and Mineral Research. 2022-11-01 - 1036 citationsNormal Bone Anatomy and PhysiologyBart L. Clarke
Clinical Journal of the American Society of Nephrology. 2008-11-01 - 116 citationsSerum 25-hydroxyvitamin D levels: variability, knowledge gaps, and the concept of a desirable rangeGhada El-Hajj Fuleihan, Roger Bouillon, Bart L. Clarke, Marlene Chakhtoura, Cyrus Cooper
Journal of Bone and Mineral Research. 2015-07-01
Lectures
- Meeting the Needs of Patients, Not LDL-C Goals: The Role of PCSK9 InhibitorENDO 2019 - New Orleans, LA - 3/25/2019
- PTH Replacement Therapy in Hypoparathyroidism: When and How to ProceedENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018
- Opening Comments: 2018 Parathyroid Summit: A Focus on HypoparathyroidismENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/19/2018
Press Mentions
Parathyroid Hormone Therapy Normalizes Calcium for Most with HypoparathyroidismOctober 15th, 2024- Providers and Patients Can Help Minimize Risks of Steroid-Induced Osteoporosis, ACR SaysSeptember 22nd, 2022
Hormonal Regulation of BiomineralizationMarch 16th, 2021- Join now to see all
Committees
- Co-Chair, ASBMR Development Committee 2014 - Present
- Member, ASBMR Council 2013 - Present
- Member, The Endocrine Society Development Committee 2009 - Present
- Member, FDA Advisory Committee on Reproductive Health Drugs 2010 - 2013
Professional Memberships
- Fellow
- Member
Other Languages
- French
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
